GSK competitorsClear all

GSK's top competitors include Merck, Johnson & Johnson, Roche, AstraZeneca, Takeda Pharmaceutical, Bayer and Eli Lilly.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
GSK
GSK
GSK (GlaxoSmithKline) is a science-led healthcare company.
Merck
Merck
Merck & Co (also known as Merck Sharp & Dohme) is a healthcare manufacturer and distributor of pharmaceuticals.
Johnson & Johnson
Johnson & Johnson
Johnson & Johnson is a global holding company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field.
Roche
Roche
Roche (also known as F. Hoffmann-La Roch) is a biotech company operating through 2 segments: Pharmaceuticals and Diagnostics.
AstraZeneca
AstraZeneca
AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
Takeda Pharmaceutical
Takeda Pharmaceutical
Takeda Pharmaceutical is a biopharmaceutical company.
Bayer
Bayer
Bayer is a global life science company specializing in healthcare and nutrition.
Eli Lilly
Eli Lilly
Eli Lilly and Company is a company that discovers, develops, manufactures, and markets pharmaceutical products.
Founding Date
Founding Date
2000
Founding Date
1891
Founding Date
1886
Founding Date
1896
Founding Date
1999
Founding Date
1781
Founding Date
1863
Founding Date
1876
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Brentford, GB HQ
Boudouaou, DZ
San Fernando, AR
Abbotsford, AU
Boronia, AU
Wien, AT
Minsk, BY
see more
Locations
Kenilworth, US HQ
Hydra, DZ
Munro, AR
Macquarie Park, AU
Wien, AT
Baku, AZ
Manama, BH
see more
Locations
New Brunswick, US HQ
Buenos Aires, AR
Chippendale, AU
Wien, AT
Minsk, BY
Beerse, BE
Brussel, BE
see more
Locations
Basel, CH HQ
Hydra, DZ
Ricardo Rojas, AR
North Ryde, AU
Sydney, AU
Wien, AT
Baku, AZ
see more
Locations
Cambridge, GB HQ
Alger, DZ
Buenos Aires, AR
Haedo, AR
Macquarie Park, AU
Macquarie Park, AU
North Ryde, AU
see more
Locations
Tokyo, JP HQ
The Rocks, AU
Linz, AT
Wien, AT
Sint Jans Molenbeek, BE
Santo Amaro, BR
Toronto, CA
see more
Locations
Leverkusen, DE HQ
Dely Ibrahim, DZ
Luanda, AO
Munro, AR
Pymble, AU
Wien, AT
Dhaka, BD
see more
Locations
Indianapolis, US HQ
Melrose Park, AU
Wien, AT
Brussel, BE
São Paulo, BR
Toronto, CA
Las Condes, CL
see more
Employees
Employees
99,4374% increase
Employees
74,0004% increase
Employees
134,5002% increase
Employees
101,4654% increase
Employees
76,1008% increase
Employees
47,4954% decrease
Employees
101,1683% decrease
Employees
35,0004% increase
Valuation ($)
Valuation ($)
98.3 b
Valuation ($)
182.4 b
Valuation ($)
431.5 b
Valuation ($)
N/A
Valuation ($)
154.6 b
Valuation ($)
53.8 b
Valuation ($)
52.8 b
Valuation ($)
218.9 b
Twitter followers
Twitter followers
228.4 k
Twitter followers
212.7 k
Twitter followers
239.6 k
Twitter followers
235.1 k
Twitter followers
291.4 k
Twitter followers
N/A
Twitter followers
180.1 k
Twitter followers
132 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
78
Number of tweets (last 30 days)
29
Number of tweets (last 30 days)
121
Number of tweets (last 30 days)
48
Number of tweets (last 30 days)
53
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
35
Number of tweets (last 30 days)
29
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
11.6
Average likes per tweet (last 30 days)
19.2
Average likes per tweet (last 30 days)
3.2
Average likes per tweet (last 30 days)
14.7
Average likes per tweet (last 30 days)
35.9
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
13.2
Average likes per tweet (last 30 days)
5.6
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
91.03%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
26.45%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
88.68%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
68.57%
Percentage of tweets with engagement (last 30 days)
55.17%
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
65117
Alexa Website Rank
13415
Alexa Website Rank
48352
Alexa Website Rank
45419
Alexa Website Rank
183252
Alexa Website Rank
65651
Alexa Website Rank
125956
Employee Rating
Employee Rating
3.9
Employee Rating
4.2
Employee Rating
4.2
Employee Rating
4.3
Employee Rating
4.2
Employee Rating
3.9
Employee Rating
4.4
Employee Rating
4.1

Financial

Revenue (est.)
Revenue (est.)
£33.8b (FY, 2019)
Revenue (est.)
$48b (FY, 2020)
Revenue (est.)
$82.1b (FY, 2019)
Revenue (est.)
CHF63.8b (FY, 2019)
Revenue (est.)
$24.4b (FY, 2019)
Revenue (est.)
¥3.3t (FY, 2020)
Revenue (est.)
€43.5b (FY, 2019)
Revenue (est.)
$24.5b (FY, 2020)
Cost of goods
Cost of goods
£11.9b (FY, 2019)
Cost of goods
$15.5b (FY, 2020)
Cost of goods
$27.6b (FY, 2019)
Cost of goods
CHF18.4b (FY, 2019)
Cost of goods
$4.9b (FY, 2019)
Cost of goods
¥1.1t (FY, 2020)
Cost of goods
€17.5b (FY, 2019)
Cost of goods
$5.5b (FY, 2020)
Gross profit
Gross profit
£21.9b (FY, 2019)
Gross profit
$32.5b (FY, 2020)
Gross profit
$54.5b (FY, 2019)
Gross profit
CHF45.4b (FY, 2019)
Gross profit
$19.5b (FY, 2019)
Gross profit
¥2.2t (FY, 2020)
Gross profit
€26.1b (FY, 2019)
Gross profit
$19.1b (FY, 2020)
Net income
Net income
£5.3b (FY, 2019)
Net income
$7.1b (FY, 2020)
Net income
$15.1b (FY, 2019)
Net income
CHF14.1b (FY, 2019)
Net income
$1.2b (FY, 2019)
Net income
¥44.3b (FY, 2020)
Net income
€2.4b (FY, 2019)
Net income
$6.2b (FY, 2020)

Operating

Countries
Countries
N/A
Countries
N/A
Countries
60 (FY, 2018)
Countries
N/A
Countries
100 (FY, 2020)
Countries
N/A
Countries
153 (FY, 2018)
Countries
120 (FY, 2019)
Filed Trials Products (Oncology)
Filed Trials Products (Oncology)
N/A
Filed Trials Products (Oncology)
N/A
Filed Trials Products (Oncology)
N/A
Filed Trials Products (Oncology)
3 (Dec, 2020)
Filed Trials Products (Oncology)
N/A
Filed Trials Products (Oncology)
8 (Oct, 2020)
Filed Trials Products (Oncology)
N/A
Filed Trials Products (Oncology)
N/A
Manufacturing Facilities
Manufacturing Facilities
87 (FY, 2016)
Manufacturing Facilities
N/A
Manufacturing Facilities
97 (FY, 2019)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Patients Included in Clinical Trials
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
282.5 k (FY, 2019)
Patients Included in Clinical Trials
33 k (FY, 2017)
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
N/A
Patients Included in Clinical Trials
N/A
Phase I Trials Products
Phase I Trials Products
12 (FY, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
27 (FY, 2019)
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
43 (Dec, 2020)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
1 (Jul, 2019)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
32 (Nov, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
12 (Jan, 2020)
Phase II Trials Products
9 (FY, 2019)
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
7 (Dec, 2020)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
8 (Oct, 2019)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products
Phase III Trials Products
14 (FY, 2019)
Phase III Trials Products
25 (Nov, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
9 (Jan, 2020)
Phase III Trials Products
15 (FY, 2019)
Phase III Trials Products (Neuroscience)
Phase III Trials Products (Neuroscience)
N/A
Phase III Trials Products (Neuroscience)
N/A
Phase III Trials Products (Neuroscience)
N/A
Phase III Trials Products (Neuroscience)
2 (Dec, 2020)
Phase III Trials Products (Neuroscience)
N/A
Phase III Trials Products (Neuroscience)
1 (Feb, 2020)
Phase III Trials Products (Neuroscience)
N/A
Phase III Trials Products (Neuroscience)
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
26 (Dec, 2020)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
5 (Oct, 2020)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
10 (May, 2018)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
171 (FY, 2020)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
66 (FY, 2016)
Suppliers
Suppliers
N/A
Suppliers
N/A
Suppliers
3.5 k (Jun, 2018)
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
86.4 k (FY, 2019)
Suppliers
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 5.6m
Total funding raised
N/A
Total funding raised
$ 2.8b
Total funding raised
$ 1b
Total funding raised
$ 57.8m
Total funding raised
$ 3.5b
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Merck
HQ
Kenilworth, US
Employees
74,000↑ 4% increase

Merck & Co (also known as Merck Sharp & Dohme) is a healthcare manufacturer and distributor of pharmaceuticals.

View company
Johnson & Johnson
HQ
New Brunswick, US
Employees
134,500↑ 2% increase

Johnson & Johnson is a global holding company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field.

View company
Roche
HQ
Basel, CH
Employees
101,465↑ 4% increase

Roche (also known as F. Hoffmann-La Roch) is a biotech company operating through 2 segments: Pharmaceuticals and Diagnostics.

View company
AstraZeneca
HQ
Cambridge, GB
Employees
76,100↑ 8% increase

AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.

View company